Breaking News
FLASH SALE 0
⚡ FLASH SALE: Spot opportunities like a pro? Here's one: InvestingPro at 50% off
Claim sale
Close

Roche Holding AG (RO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
321.00 -2.20    -0.68%
12:35:59 - Closed. Currency in CHF
Type:  Equity
Market:  Switzerland
ISIN:  CH0012032113 
VALOR:  1203211
  • Volume: 23,718
  • Bid/Ask: 320.00 / 320.00
  • Day's Range: 318.60 - 323.00
Roche Holding 321.00 -2.20 -0.68%

RO Candlestick Patterns

 
Explore Roche Holding candlestick charts and patterns to gain a deeper understanding of price movements and trends. Analyze essential data, including open, high, low, and close values, while identifying candlestick patterns that signal potential market shifts. Perfect for technical analysis, this tool helps you spot key support and resistance levels, price momentum, and market sentiment. With customizable time frames and detailed pattern recognition, this page equips you with the insights needed to refine your trading strategy.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Customize

Candlestick Patterns

Time Frame
Pattern Indication
Type
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Doji Star Bearish 1M Current
Deliberation Bearish 1M Current
Inverted Hammer 5H Current
Completed Patterns
Morning Doji Star 1M 2 Jan 25
Morning Star 1M 2 Jan 25
Bullish doji Star 1M 3 Dec 24
Rising Three Methods 1D 3 Mar 21, 2025
On Neck Bearish 15 3 Mar 26, 2025 11:30AM
Harami Bullish 1M 5 Oct 24
Harami Cross 1M 5 Oct 24
Deliberation Bearish 1W 5 Feb 16, 2025
Doji Star Bearish 1W 5 Feb 16, 2025
Upside Gap Three Methods 5H 6 Mar 24, 2025 02:00AM
Bullish Engulfing 1H 6 Mar 26, 2025 06:00AM
Harami Cross Bearish 1M 7 Aug 24
Three Inside Up 1D 7 Mar 17, 2025
Belt Hold Bearish 15 8 Mar 26, 2025 10:15AM
Abandoned Baby Bearish 30 9 Mar 26, 2025 07:30AM
Evening Doji Star 30 9 Mar 26, 2025 07:30AM
Evening Star 30 9 Mar 26, 2025 07:30AM
Bullish Engulfing 5H 10 Mar 20, 2025 03:00AM
Doji Star Bearish 30 10 Mar 26, 2025 07:00AM
Abandoned Baby Bearish 15 11 Mar 26, 2025 09:30AM
Evening Doji Star 15 11 Mar 26, 2025 09:30AM
Evening Star 15 11 Mar 26, 2025 09:30AM
Doji Star Bearish 15 12 Mar 26, 2025 09:15AM
Falling Three Methods 1M 13 Feb 24
Shooting Star 1H 14 Mar 25, 2025 07:00AM
Three Inside Up 1M 15 Dec 23
Falling Three Methods 1W 15 Dec 08, 2024
Harami Bullish 1M 16 Nov 23
Harami Cross 1M 16 Nov 23
Harami Bullish 5H 16 Mar 18, 2025 01:00AM
Doji Star Bearish 1H 16 Mar 25, 2025 05:00AM
Bullish Hammer 1W 18 Nov 17, 2024
Belt Hold Bullish 1D 18 Feb 28, 2025
Abandoned Baby Bearish 15 18 Mar 26, 2025 07:30AM
Evening Doji Star 15 18 Mar 26, 2025 07:30AM
Evening Star 15 18 Mar 26, 2025 07:30AM
Three Black Crows 1W 19 Nov 10, 2024
Deliberation Bearish 15 19 Mar 26, 2025 07:15AM
Doji Star Bearish 15 19 Mar 26, 2025 07:15AM
Three Outside Down 1W 20 Nov 03, 2024
Harami Bearish 5H 20 Mar 14, 2025 12:00PM
Belt Hold Bullish 1H 21 Mar 24, 2025 09:00AM
Belt Hold Bullish 15 21 Mar 26, 2025 06:30AM
Three Outside Up 1M 22 May 23
Bullish Engulfing 1M 23 Apr 23
Downside Gap Three Methods 1M 23 Apr 23
Stick Sandwich 1H 23 Mar 24, 2025 07:00AM
Three Outside Up 30 25 Mar 25, 2025 08:30AM
Engulfing Bearish 5H 26 Mar 12, 2025 10:00AM
Belt Hold Bullish 30 26 Mar 25, 2025 08:00AM
Bullish Engulfing 30 26 Mar 25, 2025 08:00AM
Belt Hold Bullish 15 26 Mar 26, 2025 05:15AM
Three Outside Down 1M 27 Dec 22
Falling Three Methods 1M 27 Dec 22
Shooting Star 5H 27 Mar 12, 2025 05:00AM
Engulfing Bearish 1M 28 Nov 22
Belt Hold Bearish 1D 28 Feb 14, 2025
Harami Bullish 30 28 Mar 25, 2025 07:00AM
Harami Cross 30 28 Mar 25, 2025 07:00AM
Belt Hold Bearish 30 29 Mar 25, 2025 06:30AM
Bullish doji Star 15 30 Mar 26, 2025 04:15AM
Harami Bullish 15 30 Mar 26, 2025 04:15AM
Harami Cross 15 30 Mar 26, 2025 04:15AM
Bullish Engulfing 1M 32 Jul 22
Three Black Crows 1M 33 Jun 22
Bullish Hammer 1M 33 Jun 22
Three Outside Up 30 33 Mar 25, 2025 04:30AM
Falling Three Methods 1M 34 May 22
Belt Hold Bullish 30 34 Mar 25, 2025 04:00AM
Bullish Engulfing 30 34 Mar 25, 2025 04:00AM
Three Inside Up 1M 36 Mar 22
Bullish Engulfing 5H 36 Mar 06, 2025 08:00AM
Belt Hold Bullish 15 36 Mar 25, 2025 11:30AM
Harami Bullish 1M 37 Feb 22
Harami Cross 1M 37 Feb 22
Belt Hold Bullish 5H 38 Mar 05, 2025 07:00AM
Bullish Engulfing 5H 38 Mar 05, 2025 07:00AM
Harami Bullish 1H 38 Mar 20, 2025 10:00AM
Bullish doji Star 15 39 Mar 25, 2025 10:45AM
Harami Bullish 15 39 Mar 25, 2025 10:45AM
Harami Cross 15 39 Mar 25, 2025 10:45AM
Engulfing Bearish 1M 42 Sep 21
Upside Gap Three Methods 1M 42 Sep 21
Three Inside Up 1W 42 Jun 02, 2024
Engulfing Bearish 1H 42 Mar 20, 2025 06:00AM
Belt Hold Bullish 30 42 Mar 24, 2025 09:00AM
Bullish Engulfing 1H 44 Mar 20, 2025 04:00AM
Belt Hold Bullish 30 44 Mar 24, 2025 08:00AM
Inverted Hammer 30 44 Mar 24, 2025 08:00AM
Three Inside Up 1D 46 Jan 21, 2025
Engulfing Bearish 1W 47 Apr 28, 2024
Harami Bullish 1D 47 Jan 20, 2025
Belt Hold Bullish 5H 47 Feb 28, 2025 02:00AM
Three Inside Up 30 47 Mar 24, 2025 06:30AM
Harami Cross 1W 48 Apr 21, 2024
Belt Hold Bearish 1D 48 Jan 17, 2025
Engulfing Bearish 1D 48 Jan 17, 2025
Engulfing Bearish 1M 49 Feb 21
Three Outside Up 1D 49 Jan 16, 2025
Bullish Engulfing 1D 50 Jan 15, 2025
Belt Hold Bullish 15 50 Mar 25, 2025 08:00AM
Belt Hold Bullish 30 51 Mar 24, 2025 04:30AM
Belt Hold Bullish 15 51 Mar 25, 2025 07:45AM
Harami Bullish 1M 52 Nov 20
Inverted Hammer 1M 52 Nov 20
Bullish Engulfing 1W 52 Mar 24, 2024
Harami Bullish 1H 52 Mar 19, 2025 05:00AM
Harami Cross 1H 52 Mar 19, 2025 05:00AM
Harami Cross 15 52 Mar 25, 2025 07:30AM
Harami Bullish 15 52 Mar 25, 2025 07:30AM
Three Outside Down 1W 53 Mar 17, 2024
Belt Hold Bullish 5H 53 Feb 26, 2025 12:00AM
Inverted Hammer 1M 54 Sep 20
Engulfing Bearish 1W 54 Mar 10, 2024
On Neck Bearish 30 54 Mar 21, 2025 12:00PM
Harami Bullish 30 54 Mar 21, 2025 12:00PM
Harami Cross 30 54 Mar 21, 2025 12:00PM
Belt Hold Bullish 15 54 Mar 25, 2025 07:00AM
Bullish Engulfing 15 54 Mar 25, 2025 07:00AM
Harami Bullish 1M 55 Aug 20
Bullish Engulfing 30 56 Mar 21, 2025 11:00AM
Abandoned Baby Bearish 1M 57 Jun 20
Engulfing Bearish 1M 57 Jun 20
Hanging Man 1D 57 Jan 06, 2025
Doji Star Bearish 1M 58 May 20
Belt Hold Bullish 1H 58 Mar 18, 2025 08:00AM
Three Inside Up 1M 59 Apr 20
Bullish Engulfing 1M 59 Apr 20
Harami Cross 1M 60 Mar 20
Harami Bullish 1M 60 Mar 20
Gravestone Doji 15 60 Mar 25, 2025 05:30AM
Engulfing Bearish 1M 61 Feb 20
Harami Bullish 1W 61 Jan 21, 2024
Harami Cross 1W 61 Jan 21, 2024
Harami Cross Bearish 1W 63 Jan 07, 2024
Three Inside Down 1D 63 Dec 19, 2024
Harami Cross 1H 64 Mar 17, 2025 11:00AM
Dragonfly Doji 1H 64 Mar 17, 2025 11:00AM
Harami Bullish 1H 64 Mar 17, 2025 11:00AM
Hanging Man 1M 65 Oct 19
Belt Hold Bullish 15 66 Mar 25, 2025 04:00AM
Bullish Engulfing 15 66 Mar 25, 2025 04:00AM
Belt Hold Bullish 1D 69 Dec 11, 2024
Bullish Engulfing 1D 69 Dec 11, 2024
Doji Star Bearish 30 69 Mar 21, 2025 04:30AM
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RO Comments

Write your thoughts about Roche Holding AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Joe Jordan
Joe Jordan May 21, 2024 5:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
Joe Jordan
Joe Jordan May 21, 2024 5:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate Thursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the treatment of obesity and type 2 diabetes. The study found that a once-weekly subcutaneous injection of CT-388 over 24 weeks resulted in significant weight loss in healthy adults with obesity compared to placebo.
Sherlyn Jones
Sherlyn Jones Apr 22, 2021 6:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
Lee John
Lee John Nov 16, 2020 3:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
13.11.2020. CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza. This CHMP recommendation brings patients with influenza one step closer to potentially benefiting from Xofluza’s oral one-dose regimen, setting adults and adolescents on the path to feeling better sooner compared to placebo,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “We believe that access to effective antivirals for influenza, and particularly their use in the prophylactic setting, could help reduce the strain of the COVID-19 pandemic on healthcare systems in Europe.
Jonny Tr
Jonny Tr May 04, 2020 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just like Biolidics. they get approval for Covid19 tests kits in USA
Billy Hanafi
Billy Hanafi Jan 25, 2019 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
edgard hajjar
edgard hajjar May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is the historical price adjusted for stock splits?
Billy Hanafi
Billy Hanafi May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email